PDGFRa and aSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis.
V. Biasin (Graz, Austria), S. Crnkovic (Graz, Austria), A. Sahu-Osen (Graz, Austria), A. Birnhuber (Graz, Austria), E. El Agha (Giessen, Germany), K. Sinn (Vienna, Austria), W. Klepetko (Vienna, Austria), A. Olschewski (Graz, Austria), S. Bellusci (Giessen, Germany), L. Marsh (Graz, Austria), G. Kwapiszewska (Graz, Austria)
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Biasin (Graz, Austria), S. Crnkovic (Graz, Austria), A. Sahu-Osen (Graz, Austria), A. Birnhuber (Graz, Austria), E. El Agha (Giessen, Germany), K. Sinn (Vienna, Austria), W. Klepetko (Vienna, Austria), A. Olschewski (Graz, Austria), S. Bellusci (Giessen, Germany), L. Marsh (Graz, Austria), G. Kwapiszewska (Graz, Austria). PDGFRa and aSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis.. 3374
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: